Review
doi: 10.1200/JCO.2012.42.8375.
Epub 2012 Apr 3.
American Society of Clinical Oncology identifies five key opportunities to improve care and reduce costs: the top five list for oncology
Affiliations
- PMID: 22493340
- DOI: 10.1200/JCO.2012.42.8375
Item in Clipboard
Review
American Society of Clinical Oncology identifies five key opportunities to improve care and reduce costs: the top five list for oncology
J Clin Oncol.
.
No abstract available
Comment in
-
Appropriateness and right price: an inseparable binomial to improve care and reduce cost.J Clin Oncol. 2013 Jun 10;31(17):2223. doi: 10.1200/JCO.2012.44.1196. Epub 2013 May 6. J Clin Oncol. 2013. PMID: 23650418 No abstract available.
-
Integrating molecular biology into clinical practice.J Clin Oncol. 2013 Jun 10;31(17):2222. doi: 10.1200/JCO.2012.44.2822. Epub 2013 May 6. J Clin Oncol. 2013. PMID: 23650426 No abstract available.
-
Reply to M.F. Barginear et al and S. Crispino et al.J Clin Oncol. 2013 Jun 10;31(17):2223-4. doi: 10.1200/JCO.2012.45.1153. J Clin Oncol. 2013. PMID: 23901418 No abstract available.
Similar articles
-
American Society of Clinical Oncology guidance statement: the cost of cancer care.J Clin Oncol. 2009 Aug 10;27(23):3868-74. doi: 10.1200/JCO.2009.23.1183. Epub 2009 Jul 6. J Clin Oncol. 2009. PMID: 19581533
-
Revised RECIST guideline version 1.1: What oncologists want to know and what radiologists need to know.AJR Am J Roentgenol. 2010 Aug;195(2):281-9. doi: 10.2214/AJR.09.4110. AJR Am J Roentgenol. 2010. PMID: 20651182
-
The American Society of Clinical Oncology guideline program.Pharm Pract Manag Q. 1996 Apr;16(1):31-8. Pharm Pract Manag Q. 1996. PMID: 10157738 No abstract available.
-
Clinical Cancer Advances 2009: major research advances in cancer treatment, prevention, and screening--a report from the American Society of Clinical Oncology.J Clin Oncol. 2009 Dec 10;27(35):6052-69. doi: 10.1200/JCO.2009.26.6171. Epub 2009 Nov 9. J Clin Oncol. 2009. PMID: 19901123 Review. No abstract available.
-
[Choosing wisely recommendations in hematology and oncology].Internist (Berl). 2017 Jun;58(6):545-549. doi: 10.1007/s00108-017-0249-5. Internist (Berl). 2017. PMID: 28497377 Review. German.
Cited by
-
Can Ki-67 serve as a suitable marker to indicate the necessity of staging diagnostics in cases of low-risk breast cancer?Arch Gynecol Obstet. 2024 Oct 30. doi: 10.1007/s00404-024-07753-2. Online ahead of print. Arch Gynecol Obstet. 2024. PMID: 39476005
-
Differences in Health Care Expenditures by Cancer Patients During Their Last Year of Life: A Registry-Based Study.Curr Oncol. 2024 Oct 16;31(10):6205-6217. doi: 10.3390/curroncol31100462. Curr Oncol. 2024. PMID: 39451766 Free PMC article.
-
Appropriateness of Imaging for Low-Risk Prostate Cancer-Real World Data from the Pennsylvania Urologic Regional Collaboration (PURC).Curr Oncol. 2024 Aug 20;31(8):4746-4752. doi: 10.3390/curroncol31080354. Curr Oncol. 2024. PMID: 39195337 Free PMC article.
-
Addressing financial hardship in malignant hematology and hematopoietic cell transplant: a team approach.Blood Adv. 2024 Oct 8;8(19):5146-5155. doi: 10.1182/bloodadvances.2024012998. Blood Adv. 2024. PMID: 39146495 Free PMC article.
-
What does "urgency" mean when prioritizing cancer treatment? Results from a qualitative study with German oncologists and other experts during the COVID-19 pandemic.J Cancer Res Clin Oncol. 2024 Jul 15;150(7):352. doi: 10.1007/s00432-024-05863-7. J Cancer Res Clin Oncol. 2024. PMID: 39009898 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
